Skip to main content

Table 1 Baseline characteristics of non-DM patients stratified according to admission glucose

From: High admission glucose levels predict worse short-term clinical outcome in non-diabetic patients with acute myocardial infraction: a retrospective observational study

  AG ≤ 140 mg/dL
M (P25, P75)
N = 1216
140 mg/dL<AG<180 mg/dL
M (P25, P75)
N = 370
AG ≥ 180 mg/dL
M (P25, P75)
N = 112
P
Age (years) 63 (55, 76) 64 (57, 76) 66 (57, 73) 0.022
SBP (mmHg) 127 (114, 141) 124.00 (109.75, 138.00) 125.5 (110.00, 143.75) 0.008
FPG (mg/dL) 91.08 (83.16, 101.11) 101.7 (91.26, 114.71) 109.17 (92.88, 136.80) <0.001
AG (mg/dL) 114.12 (103.36, 125.77) 153.36 (146.11, 163.8) 204.75 (190.21, 229.63) <0.001
HbA1C(%) 5.60 (5.3, 5.8) 5.70 (5.4, 6.0) 5.80 (5.60, 6.20) <0.001
hs-CRP (ng/ml) 6.77 (2.25, 15.26) 7.47 (2.58, 15.95) 8.93 (2.64, 21.21) 0.201
TC (mmol/L) 4.34 (3.72, 5.08) 4.39 (3.75, 4.99) 4.23 (3.58, 4.81) 0.363
LDL-C (mmol/L) 2.51 (2.02, 3.04) 2.50 (2.06, 2.97) 2.44 (1.93, 2.87) 0.250
Cr (mg/dL) 0.95 (0.84, 1.09) 1.05 (0.83, 1.08) 0.98 (0.84, 1.20) 0.228
eGFR (ml/min·1.73m2) 80.70 (64.52, 94.89) 77.26 (65.51, 93.53) 76.51 (60.17, 87.93) 0.094
log NT-proBNP 3.16 (2.68, 3.66) 3.27 (2.78, 3.80) 3.33 (2.99, 3.87) <0.001
CK-MB ( ng/ml) 32.10 (4.5, 105.16) 59.89 ( 7.9, 165.75) 74.90 ( 17.35, 209.25) <0.001
cTnI ( ng/ml) 3.31 (0.53, 13.23) 6.21 (0.56, 20.17) 5.95 (1.18, 33.28) <0.001
MYO (ng/ml) 101.5 (35.6, 250.94) 150.50 (49.83, 301.36) 175.39 (82.78, 428.25) <0.001
EF 0.61 (0.54, 0.66) 0.59 (0.51, 0.66) 0.58 (0.51, 0.64) 0.003
HS (day) 8.0 (6.0, 10.0) 8.0 (6.0, 11.0) 8.0 (6.0, 10.0) 0.149
Male 930 (76.5) 269 (72.7) 130 (76.8) 0.32
Age over 75 324 (26.6) 110 (29.7) 25 (22.3) 0.25
EF below 0.4 88 (7.2) 27 (7.3) 7 (6.2) 0.92
STEMI 585 (48.1) 229 (61.9) 75 (67.0) <0.001
PCI 883 (72.6) 285 (77.0) 89 (79.5) 0.09
IMR 14 (1.2) 15 (4.1) 6 (5.4) <0.001
OMI 130 (10.7) 43 (11.6) 11 (9.8) 0.82
Hypertension 7718 (59.0) 241 (65.1) 72 (64.3) 0.08
Dyslipidemia 511 (42.0) 170 (45.9) 52 (46.4) 0.32
CKD 55 (4.5) 19 (5.1) 5 (4.5) 0.88
Stroke history 167 (13.7) 65 (17.6) 14 (12.5) 0.15
Current smoking 589 (48.4) 159 (43.0) 48 (42.9) 0.12
Medication befor admission
 Aspirin 134 (11) 33 (8.9) 16 (14.3) 0.24
 CCB 325 (26.7) 115 (31.1) 37 (33.0) 0.13
 β-blocker 131 (10.8) 48 (13.0) 13 (11.6) 0.50
 ACEI 104 (8.6) 36 (9.7) 9 (8.0) 0.75
 ARB 177 (14.6) 44 (11.9) 19 (17) 0.29
 Statin 136 (11.2) 56 (15) 10 (8.9) 0.07
  1. AG Admission glucose, SBP Systolic blood pressure, FPG Fasting plasma glucose, HbA1c Glycosylated hemoglobin, hs-CRP High-sensitivity C-reactive protein, TC Total cholesterol, LDL-C Low-density lipoprotein cholesterol, Cr Creatinine, eGFR estimated glomerular filtration rate, NT-proBNP N-terminal pro-brain natriuretic peptide, CK-MB Creatine kinase-MB, cTnI Cardiac troponin I, MYO Myoglobin, EF Ejection fraction, HS Hospital stay, STEMI ST-segment elevation myocardial infraction, PCI Percutaneous coronary intervention, IMR Insufficient myocardium reperfusion, OMI Old myocardial infraction, CKD Chronic Kidney Disease, CCB Calcium channel blocker, ACEI Angiotensin-converting enzyme inhibitor, ARB Angiotensin receptor blocker